Sepsis Risk Study in Chinese ICU Patients
Part of Infections clinical trials.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older and in the ICU.
- If you have sepsis, it must have started within 72 hours of being in the ICU.
- If you don't have sepsis, you must be in the ICU for at least 24 hours without signs of infection.
- You cannot have end-stage organ failure (like severe kidney, liver, or heart disease) or cancer that has spread.
- You must not have a weak immune system (from autoimmune disease or certain medicines in the last 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This study looks at the outcomes of people hospitalized with sepsis in China. It helps doctors understand how patients respond to treatment and what factors affect recovery.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.